Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Shapiro

Showing results (121-130 of 197) with videos related to

Pageof 20
Sort By:
Taiwan Journal of Ophthalmology|January 15, 2019
Bevacizumab or laser for aggressive posterior retinopathy of prematurityMichael Blair, Jose Maria Garcia Gonzalez, Laura Snyder, et al.
Journal of the American College of Cardiology|November 12, 2025
Interplay of Coronary Artery Calcium and PREVENT Equations in Atherosclerotic Cardiovascular Disease Risk PredictionIsaac Acquah, Kobina Hagan, Michael Shapiro, et al.
JACC. Case Reports|April 18, 2025
Inadequate Response to PCSK9 InhibitorsTia Bimal, Tanesh Ayyalu, Maya S Safarova, et al.
Transfusion|December 2, 2017
Intravenous immunoglobulin-induced acute thrombocytopeniaAnna Gurevich-Shapiro, Lilach Bonstein, Galia Spectre, et al.
Plos Pathogens|September 9, 2011
A novel persistence associated EBV miRNA expression profile is disrupted in neoplasiaJin Qiu, Katherine Cosmopoulos, Michiel Pegtel, et al.
Journal of the American Academy of Dermatology|May 1, 2007
Eruptive disseminated Spitz neviRoss M Levy, Michael E Ming, Michael Shapiro, et al.
Plos One|May 28, 2020
New York State dairy farmers' perceptions of antibiotic use and resistance: A qualitative interview studyMichelle Wemette, Amelia Greiner Safi, Wendy Beauvais, et al.
Chemical Research in Toxicology|September 17, 2002
NMR-based metabonomic studies on the biochemical effects of commonly used drug carrier vehicles in the ratBridgette M Beckwith-Hall, Elaine Holmes, John C Lindon, et al.
Journal of the American Academy of Dermatology|November 27, 2002
Novel multimodality biologic response modifier therapy, including bexarotene and long-wave ultraviolet A for a patient with refractory stage IVa cutaneous T-cell lymphomaMichael Shapiro, Alain H Rook, Michael S Lehrer, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
The Epidemiology of Multidrug-Resistant Sepsis among Chronic Hemodialysis PatientsShani Zilberman-Itskovich, Yazid Elukbi, Roni Weinberg Sibony, et al.
Pageof 20

Showing results (121-130 of 197) with videos related to

Sort By:
Pageof 20
Taiwan Journal of Ophthalmology|January 15, 2019
Bevacizumab or laser for aggressive posterior retinopathy of prematurityMichael Blair, Jose Maria Garcia Gonzalez, Laura Snyder, et al.
Journal of the American College of Cardiology|November 12, 2025
Interplay of Coronary Artery Calcium and PREVENT Equations in Atherosclerotic Cardiovascular Disease Risk PredictionIsaac Acquah, Kobina Hagan, Michael Shapiro, et al.
JACC. Case Reports|April 18, 2025
Inadequate Response to PCSK9 InhibitorsTia Bimal, Tanesh Ayyalu, Maya S Safarova, et al.
Transfusion|December 2, 2017
Intravenous immunoglobulin-induced acute thrombocytopeniaAnna Gurevich-Shapiro, Lilach Bonstein, Galia Spectre, et al.
Plos Pathogens|September 9, 2011
A novel persistence associated EBV miRNA expression profile is disrupted in neoplasiaJin Qiu, Katherine Cosmopoulos, Michiel Pegtel, et al.
Journal of the American Academy of Dermatology|May 1, 2007
Eruptive disseminated Spitz neviRoss M Levy, Michael E Ming, Michael Shapiro, et al.
Plos One|May 28, 2020
New York State dairy farmers' perceptions of antibiotic use and resistance: A qualitative interview studyMichelle Wemette, Amelia Greiner Safi, Wendy Beauvais, et al.
Chemical Research in Toxicology|September 17, 2002
NMR-based metabonomic studies on the biochemical effects of commonly used drug carrier vehicles in the ratBridgette M Beckwith-Hall, Elaine Holmes, John C Lindon, et al.
Journal of the American Academy of Dermatology|November 27, 2002
Novel multimodality biologic response modifier therapy, including bexarotene and long-wave ultraviolet A for a patient with refractory stage IVa cutaneous T-cell lymphomaMichael Shapiro, Alain H Rook, Michael S Lehrer, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
The Epidemiology of Multidrug-Resistant Sepsis among Chronic Hemodialysis PatientsShani Zilberman-Itskovich, Yazid Elukbi, Roni Weinberg Sibony, et al.
Pageof 20